MedVital: Innovating Wound Care and Aesthetics

MedVital, a medtech startup concentrating on wound care and regenerative aesthetics, has successfully secured Rs 18 crore (approximately $1.89 million) in a funding round aimed at growth, spearheaded by Alkemi Growth Capital. This funding event also saw contributions from Sanjay Arora, Shubhan Ventures, and previous investors. The company had earlier acquired funding from 4point0 Health Ventures along with support from other angel investors.

Expanding Operations

The funds raised will be allocated towards expanding operations, speeding up product development, and enhancing capabilities in devices, biomaterials, and biologics. Established in 2024, MedVital focuses on creating medical technologies within advanced wound care, regenerative aesthetics, and treatment for chronic skin conditions.

Advanced Wound Care Solutions

MedVital is actively involved in the advanced wound care market through its NoWound portfolio, encompassing negative pressure wound therapy systems and liquid bandage products specifically designed for hospitals. The brand asserts that it has attained widespread adoption, with over 200 healthcare institutions in India utilizing its products, resulting in repeat usage from hospitals.

Regenerative Aesthetics Product Line

Additionally, MedVital has introduced Elyara, a product line dedicated to regenerative aesthetics, which centres on non-invasive solutions for skin and hair restoration.